Use and continuity of weight‐modifying medications among adults with diabetes and overweight/obesity: US population study
出版年份 2023 全文链接
标题
Use and continuity of weight‐modifying medications among adults with diabetes and overweight/obesity: US population study
作者
关键词
-
出版物
Obesity
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-03
DOI
10.1002/oby.23869
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Obesity among Latinx people in the United States: A review
- (2023) José Orlando Alemán et al. Obesity
- Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the U.S.
- (2021) Karine Suissa et al. DIABETES OBESITY & METABOLISM
- Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
- (2021) Melanie Davies et al. LANCET
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
- (2021) Domenica Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coverage of obesity and obesity disparities on American Board of Medical Specialties (ABMS) examinations
- (2021) Siddharth Yarlagadda et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities
- (2021) Rozalina G. McCoy et al. DIABETES CARE
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018
- (2021) Michael Fang et al. NEW ENGLAND JOURNAL OF MEDICINE
- European Commission classifies obesity as a chronic disease
- (2021) Talha Burki Lancet Diabetes & Endocrinology
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications
- (2021) W Timothy Garvey JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
- (2021) Ildiko Lingvay et al. LANCET
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- (2020) Darren K. McGuire et al. JAMA Cardiology
- New directions in incidence and prevalence of diagnosed diabetes in the USA
- (2019) Stephen R Benoit et al. BMJ Open Diabetes Research & Care
- Obesity education in medical schools, residencies, and fellowships throughout the world: a systematic review
- (2019) Marissa R. Mastrocola et al. INTERNATIONAL JOURNAL OF OBESITY
- Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015
- (2019) David R. Saxon et al. Obesity
- Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study
- (2018) Guifeng Xu et al. BMJ-British Medical Journal
- Pharmacotherapy of obesity: Available medications and drugs under investigation
- (2018) Eleni Pilitsi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity
- (2017) G Gomez et al. INTERNATIONAL JOURNAL OF OBESITY
- National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care
- (2017) Donovan T. Maust et al. JOURNAL OF CLINICAL PSYCHIATRY
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY
- (2016) W. Timothy Garvey et al. Endocrine Practice
- Regarding Obesity as a Disease
- (2016) Theodore K. Kyle et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s
- (2016) Catherine E. Thomas et al. Obesity
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
- (2015) Juan Pablo Domecq et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Antipsychotic Treatment of Adults in the United States
- (2015) Mark Olfson et al. JOURNAL OF CLINICAL PSYCHIATRY
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
- (2013) R. A. DeFronzo et al. DIABETES CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now